Woody Sherman, Vice President of Applications Science, joined Schrödinger in 2004. He received his Ph.D. from MIT where he developed a novel method for optimizing ligand binding specificity across a panel of targets. While in graduate school he completed an internship at Biogen where he helped develop novel methods to enhance antibody affinity that resulted in a patent and publication. He has authored papers on induced-fit docking, binding specificity, antibody design, fragment docking, and hybrid ligand/structure-based methods. He is also co-author on two patents. Woody is a reviewer for many top journals related to computational chemistry and drug design and is on the Editorial Board of Chemical Biology & Drug Design.